Literature DB >> 9168132

Identification of critical CpG sites for repression of L1 transcription by DNA methylation.

K Hata1, Y Sakaki.   

Abstract

L1 (LINE-1) is an interspersed non-LTR retrotransposon and several genetic defects caused by L1 transposition have been reported. L1 is thus considered as a potential mutagen. However, this potentially hazardous insertional event seems to be rare in spite of the presence of 3000 or more L1 elements of full or nearly full length in the human genome. Thus there must exist a mechanism(s) for repressing the expression of most, if not all, L1 elements. Some studies suggested that methylation plays a major role in the repression of L1 expression. However, no direct evidence has been presented and further study is required to draw a conclusion. We thus studied the effect of methylation on L1 transcription in vivo and in vitro. Transfection of plasmid which contained a L1 promoter linked to cat gene into HeLa cells showed that methylation did repress the L1 promoter activity. In vitro transcription studies using mutagenized templates indicated that methylation of the first seven CpGs in L1 promoter, particularly four CpGs at +52, +58, +61 and +70 was essential for the inhibition. These results suggest that there exists a mechanism to regulate the L1 transcription through the region-specific methylation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9168132     DOI: 10.1016/s0378-1119(96)00856-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  87 in total

1.  Members of the SRY family regulate the human LINE retrotransposons.

Authors:  T Tchénio; J F Casella; T Heidmann
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  The end of the LINE?: lack of recent L1 activity in a group of South American rodents.

Authors:  N C Casavant; L Scott; M A Cantrell; L E Wiggins; R J Baker; H A Wichman
Journal:  Genetics       Date:  2000-04       Impact factor: 4.562

3.  Promoter analysis of mouse Scn3a gene and regulation of the promoter activity by GC box and CpG methylation.

Authors:  Guang-Fei Deng; Jia-Ming Qin; Xun-Sha Sun; Zu-Ying Kuang; Tao Su; Qi-Hua Zhao; Yi-Wu Shi; Xiao-Rong Liu; Mei-Juan Yu; Yong-Hong Yi; Wei-Ping Liao; Yue-Sheng Long
Journal:  J Mol Neurosci       Date:  2011-01-27       Impact factor: 3.444

Review 4.  A LINE-1 component to human aging: do LINE elements exact a longevity cost for evolutionary advantage?

Authors:  Georges St Laurent; Neil Hammell; Timothy A McCaffrey
Journal:  Mech Ageing Dev       Date:  2010-03-25       Impact factor: 5.432

5.  LINE-1 activity as molecular basis for genomic instability associated with light exposure at night.

Authors:  Victoria P Belancio
Journal:  Mob Genet Elements       Date:  2015-04-07

6.  A small family of sushi-class retrotransposon-derived genes in mammals and their relation to genomic imprinting.

Authors:  Neil A Youngson; Sylvia Kocialkowski; Nina Peel; Anne C Ferguson-Smith
Journal:  J Mol Evol       Date:  2005-09-12       Impact factor: 2.395

7.  Cell divisions are required for L1 retrotransposition.

Authors:  Xi Shi; Andrei Seluanov; Vera Gorbunova
Journal:  Mol Cell Biol       Date:  2006-12-04       Impact factor: 4.272

8.  RNA expression microarray analysis in mouse prospermatogonia: identification of candidate epigenetic modifiers.

Authors:  Christophe Lefèvre; Jeffrey R Mann
Journal:  Dev Dyn       Date:  2008-04       Impact factor: 3.780

9.  Poly(A) binding protein C1 is essential for efficient L1 retrotransposition and affects L1 RNP formation.

Authors:  Lixin Dai; Martin S Taylor; Kathryn A O'Donnell; Jef D Boeke
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

10.  Long interspersed nuclear elements (LINEs) show tissue-specific, mosaic genome and methylation-unrestricted, widespread expression of noncoding RNAs in somatic tissues of the rat.

Authors:  Deepak K Singh; Pramod C Rath
Journal:  RNA Biol       Date:  2012-10-12       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.